Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters
Authors:
Open Access
- 1 November 2011
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 52 (11) , 1965-1973
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- In vivo D2O labeling to quantify static and dynamic changes in cholesterol and cholesterol esters by high resolution LC/MSJournal of Lipid Research, 2011
- Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transportJournal of Lipid Research, 2010
- Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or AnacetrapibArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamstersJournal of Lipid Research, 2010
- Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster modelJournal of Lipid Research, 2010
- Update of the LIPID MAPS comprehensive classification system for lipidsJournal of Lipid Research, 2009
- The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosisJournal of Lipid Research, 2009
- Torcetrapib‐induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosteroneBritish Journal of Pharmacology, 2008
- HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathwayJournal of Clinical Investigation, 2006
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959